Augmentin Injection

    Augmentin Injection

    S4
    PDF Leaflet Revision Date: 29 July 2016

    API: Amoxicillin, Clavulanic Acid | Company: Gsk

    Clinical Summary

    Quick overview from the medicine insert

    Indication

    Treatment of infections caused by amoxicillin-resistant organisms.

    Dosage (summary)

    1 vial IV 1.2 g every 6-8 hours for severe infections.

    Special Populations

    • Renal impairment
    • Hepatic impairment

    Pregnancy & Breastfeeding

    Safety in pregnancy not established; avoid breastfeeding.

    Key Drug Interactions

    • Probenecid
    • Allopurinol
    • Anticoagulants

    Contraindications

    • Hypersensitivity to penicillins
    • History of jaundice with AUGMENTIN

    Common side effects

    • Diarrhoea
    • Nausea
    • Headache
    • Dizziness

    Counselling Points

    • Take with food to reduce GI upset
    • Report any allergic reactions
    • Avoid alcohol during treatment

    Serious warnings

    • Serious hypersensitivity reactions
    • Risk of superinfections
    • Monitor INR with anticoagulants
    Important Disclaimer

    The Augmentin Injection professional information leaflet below is the property of Gsk and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

    Healthcare Professionals Only

    This content is for registered healthcare professionals

    Sign in or create a free account to read the full package insert.

    Free for HPCSA-registered professionals. Powered by Medinsert.

    Successfully Stashed! 💊

    This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

    View My Favourites
    WhatsApp Email LinkedIn